CMS should monitor the effect on Medicare standalone prescription drug plans of changes in how the drug costs of high-cost ...
Specific changes are needed to lower the barriers to entry for using the hospital and insurer price transparency data, ...
A new Executive Order refocuses federal agency attention on making already-required price data easier to get and use – a ...
Copayment accumulators and maximizers have the potential to harm patients’ access to necessary medicines. Health care payers ...
Incorporating systems thinking into drug value assessment promises more realistic evaluations of the impact of new therapies, ...
Poor nutrition in the US causes more than 600,000 deaths and an estimated $1.1 trillion in health care spending and lost productivity annually, as well as profound health disparities. Food Is Medicine ...
Recent policy directives from the White House seek to compel actions that are contrary to widely accepted standards of ...
President Trump campaigned on leaving the issue of abortion up to state policymakers. However, his administration has already ...
This piece, part 2 of a two-part article, addresses the rule’s proposed policies on failure to reconcile, income verification ...
It is not clear what would become of the federal government’s health care enforcement efforts without the False Claims Act’s qui tam program.
Ethical and transparent deployment of artificial intelligence can help close this risk gap by improving coding completeness ...